Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Experience proven softness, high-volume packing, minimal kickback, and exceptional detachment from the first to last coil.2-6
1. Complete proximal and distal anchor loops
Closed loops are designed to reduce implant herniation.7
2. Open loop configuration
Open loops enhance confirmability to aneurysm irregularities.7
3. Uniform loop distribution and dense neck coverage
Successive loops change direction evenly distributing loops within the aneurysm and across the neck.7
A progressive outer diameter matched to the implant size optimizes stability and volume throughout the entire coil line.3
3D | |
---|---|
Diameter (mm) | 3–25 |
Length (cm) | 6–50 |
Coil O.D. (in) | 0.0115–0.0145 |
Vol. (mm³) | 4.02–53.27 |
Soft implant
Thinner .0015” primary wire and precisely matched .0115” O.D. to fill more space.9
Random break coil
Due to its winding pattern, when the coil encounters resistance, it can more easily deflect and seek out open spaces.9
Greater package volume
Larger .0108” O.D. provides more volume in a finishing coil.3,4
Extra soft implant
0.0013“ thinner primary wire leads to a softer coil paired with a precisely-matched O.D. to fill and finish more space.2-4
(Compared to Axium™ Prime Soft coils)
Random break coil
Due to its winding pattern, when the coil encounters resistance it can more easily deflect and seek out open spaces.9
When compared to the Target™* 360 Nano™ coil, the Axium™ Prime Extra Soft coil was 47% softer. The Axium™ Prime Extra Soft coil broke at less force, resulting in less force (g) exerted against the aneurysm wall.2†
For more information about this study, read the full summary.
ES-3D | ES-Helix | SS-3D | SS-Helix | |
---|---|---|---|---|
Diameter (mm) | 1–3.5 | 1–3 | 4–6 | 4–6 |
Length (cm) | 2–10 | 1–10 | 6–20 | 6–20 |
Coil O.D. (in) | 0.0108 | 0.0108 | 0.0115 | 0.0115 |
Vol. (mm³) | 1.18–5.9 | 0.59–5.9 | 4.02–13.4 | 4.02–13.4 |
Polymer fibers: Axium™ MicroFX™ coils contain PGLA or nylon microfilaments designed to impact flow reduction and accelerate thrombosis.11
LatticeFX™ technology: LatticeFX™ technology provides an interlocked surface area or scaffold which orients cell adhesion and extracellular deposition.12
Enhanced thrombin generation with filamented coils when compared to bare platinum coils and higher thrombogenicity may be beneficial in situations where rapid occlusion is needed.12
For more information, read the study summary.
An alternative to bare platinum coils for arteriovenous fistulae and other neurovascular abnormalities.13
3D | Helix | |
---|---|---|
Diameter (mm) | 2–18 | 2–10 |
Length (cm) | 2–40 | 1–30 |
Coil O.D. (in) | 0.0115–0.0145 | 0.0115–0.0135 |
Vol. (mm³) | 1.34–42.62 | 0.67–27.7 |
An instant mechanical detachment with 99.7% proven reliability and a manual break back-up detachment method.6,14
Ball and socket design allows the coil implant to move independently of the pusher in a 360° axial rotation resulting in less energy build up and microcatheter kickout for smooth coil delivery.5,15
The Axium™ and Axium™ Prime detachable coils are not intended for all patients and may not be the appropriate treatment for all clinical scenarios. Axium™ and Axium™ Prime detachable coils are intended for the endovascular embolization of intracranial aneurysms. Axium™ and Axium™ Prime detachable coils are also intended for the embolization of other neuro vascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. Axium™ Prime Detachable Coil (Frame): The Axium™ Prime detachable coil system is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, such as arteriovenous malformations and arteriovenous fistulae. The Axium™ Prime detachable coils are also indicated for arterial and venous embolizations in the peripheral vasculature.
Whether you’re looking for procedural support, or additional information on our products and solutions – our team is here to help.
CONTACT USBased on bench testing, not indicative of clinical performance.
TRNV-14378.
TR-NV12442. Based on bench test comparing average work number of Axium™ Prime extra soft coil versus Target™* Nano™* coil. 20 units of each coil were tested. Bench testing is not indicative of clinical performance.
Determined using formula for cylinder (volume = πr2 x length). Based on calculated k-factor values.
J.B. White, C.G.M. Ken, H.J. Cloft and D/F/ Kallmes. “Coils in a NutShell: A Review of Coil Physical Properties”. 2008.”
FD3117
D00776522
TR-NV13163 (RE00046057); MP1936B; DWGS92566
TR-NV10836. Based on bench test comparing average work number of Axium™ Prime coil (super soft) versus other competitor 4x8 fill coils. 15 units of Axium™ Prime coil and 9 units of the competitor coils were tested. Bench testing is not indicative of clinical performance.
FD2948; TR-NV12051; TR-NV12197
Fargen KM, Blackburn S, Carpenter JS, et al. J NeuroIntervent Surg Published Online First: doi:10.1136/neurintsurg-2013-010887.
Girdhar G, et al, In-vitro thrombogenicity assessment of polymer filament modified and native platinum embolic coils, J Neurol Sci (2014).
Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospinpoly (D,L-lactic-co-gycolic acid) meshes. Biomaterials, 2006;27(33):5681–5688. Bashur, et.al.
M008880A001 AxiumTM Detachable Coil IFU
TR-NV13164; TR-NV13272
TR-NV12481; FD3118, TR-NV13175